apixaban mechanism of action | Apixaban: Uses, Interactions, Mechanism

Keyword	CPC	PCC	Volume	Score	Length of keyword
apixaban mechanism of action	0.32	0.6	6142	61	28
apixaban	1.43	0.3	7902	36	8
mechanism	0.65	0.6	5969	24	9
of	1.66	0.1	6637	34	2
action	1.68	0.6	1453	62	6

Keyword	CPC	PCC	Volume	Score
apixaban mechanism of action	1.12	0.3	8422	19
apixaban mechanism of action pdf	0.07	1	5659	48
apixaban mechanism of action quizlet	1.85	1	1515	9
apixaban and rivaroxaban mechanism of action	1.77	0.8	5138	71
what is the mechanism of action of apixaban	1.38	0.6	3490	8
apixaban eliquis mechanism of action	1.86	0.3	3285	31
apixaban vs warfarin mechanism of action	0.4	0.4	4317	31
apixaban method of action	1.24	0.4	460	34
expected pharmacological action of apixaban	1.24	0.6	8873	55
apixaban mode of action	1.45	0.5	5790	77
apixaban mech of action	0.5	0.9	8669	80
apixaban classification and action	0.46	0.9	8494	16
apixaban duration of action	1.75	0.9	2204	14
therapeutic effect of apixaban	1.42	0.8	3878	41
apixaban onset of action	1.12	0.9	3376	79
apixaban how it works	1.6	0.3	6570	81
apixaban mecanismo de accion	1.61	0.7	7269	84
apixaban work on which factor	0.68	0.9	6131	90
how does apixaban work in the body	0.12	0.6	2069	27
how is apixaban metabolized	1.73	0.7	7548	39

Search Results related to apixaban mechanism of action on Search Engine

Apixaban: Uses, Interactions, Mechanism of Action | DrugBank …
drugbank.com

https://go.drugbank.com/drugs/DB06605

WebMechanism of action. Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III Label. Apixaban also inhibits prothrominase Label. These effects prevent the formation of a thrombus Label.

DA: 51 PA: 40 MOZ Rank: 53

Apixaban - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK507910/

WebApr 19, 2023 · Mechanism of Action. The clotting cascade is a complex process involving multiple factors acting in three defined phases: initiation, propagation, and fibrin formation. Initiation: This step occurs when the vascular …

DA: 14 PA: 91 MOZ Rank: 7

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769096/

WebMay 14, 2019 · Mode of Action. Apixaban is a potent, direct, oral, reversible, and highly selective inhibitor of FXa (inhibitory constant = 0.08 nM [0.037 ng/mL] at 25 °C) [12, 13] that does not require antithrombin III for antithrombotic activity .

DA: 36 PA: 86 MOZ Rank: 41

Apixaban - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Apixaban

WebMechanism of action. Apixaban is a highly selective, orally bioavailable, and reversible direct inhibitor of free and clot-bound factor Xa. Factor Xa catalyzes the conversion of prothrombin to thrombin, the final enzyme in the coagulation cascade that is responsible for fibrin clot formation.

DA: 60 PA: 29 MOZ Rank: 7

Apixaban: Dosage, Mechanism/Onset of Action, Half-Life
medicine.com

https://www.medicine.com/drug/apixaban/hcp

WebFeb 17, 2020 · Mechanism of Action Inhibits platelet activation and fibrin clot formation via direct, selective and reversible inhibition of free and clot-bound factor Xa (FXa). FXa, as part of the prothrombinase complex consisting also of factor Va, calcium ions, and phospholipid, catalyzes the conversion of prothrombin to thrombin.

DA: 85 PA: 57 MOZ Rank: 53

Quick reference guide to apixaban - PMC - National Center for
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513886/

WebJul 10, 2017 · Apixaban is a selective factor Xa inhibitor, approved for use in the prevention of stroke in patients with nonvalvular atrial fibrillation and in the prevention and treatment of acute VTE. Like many of the DOACs, it has a fast onset of action and works to deliver predictable coagulation results.

DA: 12 PA: 76 MOZ Rank: 89

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
nih.gov

https://pubmed.ncbi.nlm.nih.gov/31089975/

WebApixaban is an oral, direct factor Xa inhibitor that inhibits both free and clot-bound factor Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement surgery, the treatment of deep vein thrombosis o...

DA: 69 PA: 18 MOZ Rank: 88

Apixaban | Treatment & Management | Point of Care - StatPearls
statpearls.com

https://www.statpearls.com/point-of-care/35631

WebFeb 22, 2024 · Apixaban is a novel oral anticoagulant (NOAC) approved by the US Food and Drug Administration (FDA) in 2012 for use in patients with nonvalvular atrial fibrillation to reduce the risk of stroke and blood clots, as mentioned below. [1] [2] This medication is approved for various other indications, as described below. FDA-Approved Indications.

DA: 97 PA: 17 MOZ Rank: 36

Apixaban: MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a613032.html

WebIt works by blocking the action of a certain natural substance that helps blood clots to form. How should this medicine be used? Apixaban comes as a tablet to take by mouth. It is usually taken with or without food twice a day.

DA: 84 PA: 27 MOZ Rank: 67

Apixaban (Eliquis) | Davis’s Drug Guide
drugguide.com

https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109824/all/apixaban

WebAction. Acts as a selective, reversible site inhibitor of factor Xa, inhibiting both free and bound factor. Does not affect platelet aggregation directly, but does inhibit thrombin-induced platelet aggregation. Decreases thrombin generation and thrombus development. Therapeutic Effect (s): Treatment and prevention of thromboembolic events.

DA: 77 PA: 94 MOZ Rank: 37